EFhd2, a protein linked to Alzheimer’s disease and other neurological disorders

by Irving E Vega
Published 2016-03-01

Labelling pathological tau: an important quest for the unknown

by Irving E Vega
Published 2016-06-01

EFhd2 Affects Tau Liquid–Liquid Phase Separation

by Irving E. Vega, Irving E. Vega, Irving E. Vega, Andrew Umstead, Nicholas M. Kanaan, Nicholas M. Kanaan, Nicholas M. Kanaan
Published 2019-08-01

Tau’s Three-Repeat Domain and EFhd2 Co-incubation Leads to Increased Thioflavin Signal

by Irving E. Vega, Irving E. Vega, Irving E. Vega, Alexandra Sutter, Luke Parks, Andrew Umstead, Magdalena I. Ivanova, Magdalena I. Ivanova
Published 2018-12-01

Unraveling neuroprotective and neurodegenerative signals

by Irving E Vega, Timothy J Collier
Published 2016-07-01

Profiling of Alzheimer’s disease patients in Puerto Rico: A comparison of two distinct socioeconomic areas

by Clara L Camacho-Mercado, Raúl Figueroa, Heriberto Acosta, Steven E Arnold, Irving E Vega
Published 2016-01-01

Novel autoimmune response in a tauopathy mouse model

by Carlos J Nogueras-Ortiz, Hector J De Jesus-Cortes, Jaime eVaquer-Alicea, Irving E Vega
Published 2014-01-01

Solution structure of the tandem acyl carrier protein domains from a polyunsaturated fatty acid synthase reveals beads-on-a-string configuration.

by Uldaeliz Trujillo, Edwin Vázquez-Rosa, Delise Oyola-Robles, Loren J Stagg, David A Vassallo, Irving E Vega, Stefan T Arold, Abel Baerga-Ortiz
Published 2013-01-01

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease

by Peipei Li, Bryan A. Killinger, Elizabeth Ensink, Ian Beddows, Ali Yilmaz, Noah Lubben, Jared Lamp, Meghan Schilthuis, Irving E. Vega, Randy Woltjer, J. Andrew Pospisilik, Patrik Brundin, Lena Brundin, Stewart F. Graham, Viviane Labrie
Published 2021-01-01